These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 18604951)

  • 1. Peptide-mediated delivery of nucleic acids into mammalian cells.
    Deshayes S; Simeoni F; Morris MC; Divita G; Heitz F
    Methods Mol Biol; 2007; 386():299-308. PubMed ID: 18604951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A non-covalent peptide-based strategy for ex vivo and in vivo oligonucleotide delivery.
    Crombez L; Morris MC; Heitz F; Divita G
    Methods Mol Biol; 2011; 764():59-73. PubMed ID: 21748633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A non-covalent peptide-based strategy for siRNA delivery.
    Crombez L; Divita G
    Methods Mol Biol; 2011; 683():349-60. PubMed ID: 21053142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy.
    Deshayes S; Morris M; Heitz F; Divita G
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):537-47. PubMed ID: 18037526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide vectors for the nonviral delivery of nucleic acids.
    Hoyer J; Neundorf I
    Acc Chem Res; 2012 Jul; 45(7):1048-56. PubMed ID: 22455499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of nucleic acids with a stearylated (RxR)4 peptide using a non-covalent co-incubation strategy.
    Lehto T; Abes R; Oskolkov N; Suhorutsenko J; Copolovici DM; Mäger I; Viola JR; Simonson OE; Ezzat K; Guterstam P; Eriste E; Smith CI; Lebleu B; Samir El Andaloussi ; Langel U
    J Control Release; 2010 Jan; 141(1):42-51. PubMed ID: 19744531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A non-covalent peptide-based strategy for siRNA delivery.
    Crombez L; Charnet A; Morris MC; Aldrian-Herrada G; Heitz F; Divita G
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):44-6. PubMed ID: 17233597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular delivery of peptide nucleic acid by cell-penetrating peptides.
    Kilk K; Langel U
    Methods Mol Biol; 2005; 298():131-41. PubMed ID: 16044544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of carrier peptides for the delivery of nucleic acid drugs in primary cells.
    Rennert R; Neundorf I; Jahnke HG; Suchowerskyj P; Dournaud P; Robitzki A; Beck-Sickinger AG
    ChemMedChem; 2008 Feb; 3(2):241-53. PubMed ID: 18205166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A functionalized 20-residue peptaibol derivative for nucleic acid delivery.
    Wada S; Tanaka R
    Chem Biodivers; 2007 May; 4(5):991-7. PubMed ID: 17510994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histidine-rich cationic amphipathic peptides for plasmid DNA and siRNA delivery.
    Kichler A; Mason AJ; Marquette A; Bechinger B
    Methods Mol Biol; 2013; 948():85-103. PubMed ID: 23070765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. To be targeted: is the magic bullet concept a viable option for synthetic nucleic acid therapeutics?
    Ogris M; Wagner E
    Hum Gene Ther; 2011 Jul; 22(7):799-807. PubMed ID: 21563983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape.
    Endoh T; Ohtsuki T
    Adv Drug Deliv Rev; 2009 Jul; 61(9):704-9. PubMed ID: 19383521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of cellular internalization pathways for CPP-mediated oligonucleotide delivery.
    Guterstam P; Andaloussi SE; Langel U
    Methods Mol Biol; 2011; 683():219-30. PubMed ID: 21053133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
    Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
    Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anionic amino acid-derived cationic lipid for siRNA delivery.
    Suh MS; Shim G; Lee HY; Han SE; Yu YH; Choi Y; Kim K; Kwon IC; Weon KY; Kim YB; Oh YK
    J Control Release; 2009 Dec; 140(3):268-76. PubMed ID: 19567256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of cell-penetrating peptides for cargo delivery.
    Pooga M; Langel U
    Methods Mol Biol; 2005; 298():77-89. PubMed ID: 16044541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells.
    Simeoni F; Morris MC; Heitz F; Divita G
    Nucleic Acids Res; 2003 Jun; 31(11):2717-24. PubMed ID: 12771197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleic-acid based gene therapeutics: delivery challenges and modular design of nonviral gene carriers and expression cassettes to overcome intracellular barriers for sustained targeted expression.
    Hsu CY; Uludağ H
    J Drug Target; 2012 May; 20(4):301-28. PubMed ID: 22303844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A peptide carrier for the delivery of biologically active proteins into mammalian cells.
    Morris MC; Depollier J; Mery J; Heitz F; Divita G
    Nat Biotechnol; 2001 Dec; 19(12):1173-6. PubMed ID: 11731788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.